Health Headlines: A Snapshot of Innovations and Challenges
The latest collection of health news includes EU approval for Moderna's combined flu and COVID shot, psychedelic drug shares soaring due to U.S. policy changes, and legal challenges affecting U.S. vaccine guidance. Other highlights cover Getinge's profit dip, Purdue Pharma's delayed sentencing, and AstraZeneca's lung disease drug success.
The European Commission has approved Moderna's combination flu and COVID-19 vaccine for adults 50 and over. This move signifies an important milestone in efforts to curb seasonal illness in older populations.
In another health-related development, psychedelic drug developers saw their shares rise sharply after former President Trump's directive to fast-track reviews. Industry leaders hailed this government support for research and regulatory expedite on psychedelic therapies.
Meanwhile, a U.S. court order has put COVID-19 and flu vaccine guidance on hold, as Judge Brian Murphy suspended the Advisory Committee on Immunization Practices, causing uncertainty for upcoming disease prevention strategies.
Google News